Padrón M E Torres, Ferrera Z Sosa, Rodríguez J J Santana
Department of Chemistry, Faculty of Marine Sciences, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.
Biomed Chromatogr. 2009 Nov;23(11):1175-85. doi: 10.1002/bmc.1240.
A residue analytical method combining solid-phase microextraction (SPME) with external micellar desorption (MD) and high-performance liquid chromatography with diode array detector (HPLC-DAD) has been developed and validated for the simultaneous determination of six pharmaceutical compounds, belonging to various therapeutic categories in water samples. Target compounds include antiinflamatory drugs (ibuprofen, ketoprofen and naproxen), an analgesic (phenazone), a lipid regulator (bezafibrate) and an antiepileptic (carbamazepine). A detailed study of the experimental conditions of extraction and desorption with different surfactants was performed in order to obtain the best results during instrumental analysis. Of the different fibers and surfactants investigated, 65 microm polydimethysiloxane-divinilbenzene (PDMS-DVB) fiber and polyoxyethylene 10 lauryl ether (POLE) and polyoxyethylene 6 lauryl ether (C(12)E(6)) as desorbing agents produced the optimal response to pharmaceutical residues. Recoveries obtained were generally higher than 80% and the variability of the method was below 16% for all compounds in both surfactants. Method detection limits were 0.05-12 ng mL(-1) for POLE and 0.1-5 ng mL(-1) for C(12)E(6). The developed method was compared using external desorption with organic solvent and it was successfully applied to the determination of these pharmaceutical compounds in water samples from different origin. Solid-phase microextraction with micellar desorption (SPME-MD) represents a new approach for the extraction of different pharmaceutical compounds in natural waters because it combines shorter handling time, better efficiency, safety and more environmentally friendly process than the traditional methods.
已开发并验证了一种将固相微萃取(SPME)与外部胶束解吸(MD)以及配备二极管阵列检测器的高效液相色谱(HPLC-DAD)相结合的残留分析方法,用于同时测定水样中属于不同治疗类别的六种药物化合物。目标化合物包括抗炎药(布洛芬、酮洛芬和萘普生)、一种镇痛药(非那宗)、一种脂质调节剂(苯扎贝特)和一种抗癫痫药(卡马西平)。为了在仪器分析过程中获得最佳结果,对使用不同表面活性剂进行萃取和解吸的实验条件进行了详细研究。在所研究的不同纤维和表面活性剂中,65微米的聚二甲基硅氧烷-二乙烯基苯(PDMS-DVB)纤维以及聚氧乙烯10月桂基醚(POLE)和聚氧乙烯6月桂基醚(C(12)E(6))作为解吸剂对药物残留产生了最佳响应。对于两种表面活性剂中的所有化合物,获得的回收率通常高于80%,且该方法的变异性低于16%。POLE的方法检测限为0.05 - 12 ng mL(-1),C(12)E(6)的方法检测限为0.1 - 5 ng mL(-1)。将所开发的方法与使用有机溶剂的外部解吸进行了比较,并成功应用于测定来自不同来源水样中的这些药物化合物。胶束解吸固相微萃取(SPME-MD)代表了一种用于萃取天然水中不同药物化合物的新方法,因为它与传统方法相比,具有更短的处理时间、更高的效率、安全性以及更环保的过程。